GAVIS Pharmaceuticals
GAVIS Pharmaceuticals, LLC is a privately held U.S. firm headquartered in Somerset that sells and distributes niche drug products. Founded in 2008 and operating with 11 to 50 employees, it runs a focused specialty pharmaceutical distribution model.
- Company typePrivate
- Founded2008
- HeadquartersSomerset, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What GAVIS Pharmaceuticals does
GAVIS Pharmaceuticals, LLC is a privately held U.S. pharmaceutical company engaged in the sales and distribution of niche drug products. Founded in 2008 and headquartered in Somerset (New Jersey), the company operates with a workforce of 11-50 employees, a footprint consistent with a focused, specialty-oriented distribution model rather than a broad-line or vertically integrated manufacturer-distributor. Its legal status is for-profit and unlisted; no parent company, subsidiary, or public-ticker relationship is disclosed in the supplied firmographic record.
The company's stated business model centers on commercializing and distributing a curated portfolio of drug products. Because no product list, pricing schedule, customer roster, channel mix, or technology stack has been disclosed in the available sources, the precise go-to-market mechanics, therapeutic focus, contract structure, and revenue-per-customer profile cannot be determined. The 'niche' descriptor suggests concentration in specialty, limited-competition, or underserved therapeutic categories rather than mass-market generics or branded blockbusters, but this remains an inference from the company description rather than a confirmed portfolio fact.
Public corporate disclosure is sparse. The company's website currently exposes only tracking infrastructure (a pixel/ping request) and a privacy preference link, with no substantive product, pipeline, executive, or investor content. This thin public footprint—combined with the absence of funding-round, M&A, partnership, leadership-change, or product-launch records in the supplied data—creates material intelligence gaps regarding beneficial ownership, capital structure, the active product portfolio, and the cadence and direction of recent strategic activity.
GAVIS Pharmaceuticals firmographics
Firmographics- Name
- GAVIS Pharmaceuticals
- Website
- https://gavispharma.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 11–50 employees
- Short description
- GAVIS Pharmaceuticals, LLC is a privately held U.S. firm headquartered in Somerset that sells and distributes niche drug products. Founded in 2008 and operating with 11 to 50 employees, it runs a focused specialty pharmaceutical distribution model.
- Ownership category
- akta.pro rank
GAVIS Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where GAVIS Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Somerset
- HQ country
- United States
- HQ region
- North America
Markets served
GAVIS Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel
GAVIS Pharmaceuticals product offering
Product offeringCore offering
GAVIS Pharmaceuticals, LLC is a niche drug product sales and distribution company. The firm focuses on commercializing and distributing targeted pharmaceutical drug products within specialized therapeutic niches rather than broad primary-care or blockbuster categories.
Product overview
No product information available. The source content (gavispharma.com homepage) contains only a tracking pixel and a privacy preference link, with no substantive information about GAVIS Pharmaceuticals' products, services, or portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- Niche Drug Products
Companies that use GAVIS Pharmaceuticals
Customer profileIdeal customer profiles1 record
GAVIS Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
GAVIS Pharmaceuticals partnerships and signals
Strategic signalRecent moves1 record
GAVIS Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Lannett Company: US-based specialty and generic pharmaceutical manufacturer/distributor with a portfolio concentrated in niche therapeutic categories, closely comparable to GAVIS's stated niche drug distribution model and small-mid scale.
- ANI Pharmaceuticals: Specialty generic pharmaceutical company that acquires, develops, and distributes niche prescription products across multiple therapeutic categories — directly comparable in niche distribution focus and scale to GAVIS.
- Upsher-Smith Laboratories: Specialty pharmaceutical company focused on niche generic and branded products across multiple therapeutic categories, with similar niche positioning and mid-sized footprint to GAVIS.
- Amneal Pharmaceuticals: Specialty and generic pharmaceutical manufacturer with significant niche product portfolio across CNS, endocrinology, and other specialty categories, comparable in therapeutic mix though larger scale.
- Akorn Pharmaceuticals: Specialty pharmaceutical company developing, manufacturing, and distributing niche prescription and specialty products, similar in business model and mid-market scale to GAVIS.
- Heritage Pharmaceuticals: Specialty generic pharmaceutical distributor (now part of Apotex) focused on affordable niche generic products, directly comparable in niche distribution positioning to GAVIS.
Broad incumbents
- Endo International: Specialty pharmaceutical company with diversified portfolio across multiple therapeutic areas including specialty generics, larger and more diversified than GAVIS but operating in overlapping specialty categories.
- Aurobindo Pharma USA: US arm of large Indian generic pharmaceutical manufacturer with extensive specialty and generic product offerings serving the US distribution market — broader scale than GAVIS but overlapping product categories.
- Mallinckrodt Pharmaceuticals: Specialty pharmaceutical company focused on niche therapeutic areas including CNS, autoimmune, and specialty branded products, comparable in niche focus but at significantly larger scale than GAVIS.
- Teva Pharmaceutical Industries: Largest global generic pharmaceutical manufacturer with extensive specialty and niche product offerings, representing the scaled version of the niche distribution model GAVIS operates in.
Market position
Strengths3 records
Weaknesses3 records
Key risks5 records
Key highlights4 records
Customer concentration
GAVIS Pharmaceuticals social profiles
Digital presenceGAVIS Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
GAVIS Pharmaceuticals leadership team
Management profileNumber of profiles
GAVIS Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GAVIS Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GAVIS Pharmaceuticals
What does GAVIS Pharmaceuticals do?
GAVIS Pharmaceuticals, LLC is a niche drug product sales and distribution company. The firm focuses on commercializing and distributing targeted pharmaceutical drug products within specialized therapeutic niches rather than broad primary-care or blockbuster categories.
When was GAVIS Pharmaceuticals founded?
GAVIS Pharmaceuticals was founded in 2008. It employs 11 to 50 people.
Where is GAVIS Pharmaceuticals based?
GAVIS Pharmaceuticals is headquartered in Somerset, United States, in the North America region.
Who are GAVIS Pharmaceuticals's main competitors?
Direct peers on record are Lannett Company, ANI Pharmaceuticals, Upsher-Smith Laboratories, Amneal Pharmaceuticals, Akorn Pharmaceuticals and Heritage Pharmaceuticals. Broad incumbents are Endo International, Aurobindo Pharma USA, Mallinckrodt Pharmaceuticals and Teva Pharmaceutical Industries.
Does GAVIS Pharmaceuticals have an API?
No public API is recorded for GAVIS Pharmaceuticals.
What industry is GAVIS Pharmaceuticals in?
GAVIS Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its SIC code is 5122.